Vaziri, N D <br/><br/>
Bradykinin down-regulates, whereas arginine analogs up-regulates, endothelial nitric-oxide synthase expression in coronary endothelial cells.  [electronic resource] 

 -  The Journal of pharmacology and experimental therapeutics  Apr 2005 
 - 121-6 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0022-3565 
<br/><br/><label>Standard No.: </label>10.1124/jpet.104.076497  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Arginine--analogs & derivatives<br/>Blotting, Western<br/>Bradykinin--pharmacology<br/>Cells, Cultured<br/>Coronary Vessels--cytology<br/>Down-Regulation--drug effects<br/>Endothelial Cells--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>Humans<br/>Nitric Oxide--biosynthesis<br/>Nitric Oxide Synthase--antagonists & inhibitors<br/>Nitric Oxide Synthase Type III<br/>Receptor, Bradykinin B1--drug effects<br/>Receptor, Bradykinin B2--drug effects<br/>Up-Regulation--drug effects<br/>omega-N-Methylarginine--pharmacology